Saturday, 10 October 2026European Markets

B.COM.PORTUGUES And IDI Have A High Dividend Yield And Return On Equity In The Financial Services Sector.

Loading stream...

(vianews) - b.com.portugues (bcp.ls) is among this list of stock assets with the highest dividend rate and return on equity on the financial services sector.

financial asset price forward dividend yield return on equity
b.com.portugues (bcp.ls) €0.36 5.05% 13.77%
idi (idip.pa) €74.40 4.07% 10.08%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. b.com.portugues (bcp.ls)

5.05% forward dividend yield and 13.77% return on equity

banco comercial português, s.a., a private sector bank, engages in the provision of various banking and financial products and services in portugal and internationally. it operates through retail banking; companies, corporate & investment banking; private banking; foreign business; and other segments. it offers a range of financial products and services, including current accounts, payment systems, savings and investment products, private banking, asset management, and investment banking services, such as mortgage loans, personal loans, commercial banking, leasing, factoring and insurance, and others. the company is also involved in the provision of investment fund and real estate management, e-commerce, web portal, real estate investment fund, trade finance, trust, consulting, brokerage, marketing, and real estate services, as well as internet, telephone, and mobile banking services. banco comercial português, s.a. was incorporated in 1985 and is based in porto, portugal.

earnings per share

as for profitability, b.com.portugues has a trailing twelve months eps of €0.06.

pe ratio

b.com.portugues has a trailing twelve months price to earnings ratio of 5.99. meaning, the purchaser of the share is investing €5.99 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.77%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, b.com.portugues's stock is considered to be oversold (<=20).

revenue growth

year-on-year quarterly revenue growth declined by 13.4%, now sitting on 3.35b for the twelve trailing months.

more news about b.com.portugues.

2. idi (idip.pa)

4.07% forward dividend yield and 10.08% return on equity

idi is a private equity firm specializing in leveraged buyouts, expansion capital, middle market, growth capital, acquisition of significant holdings in listed small and medium companies and secondary private equity portfolios, mezzanine financing, loans senior to senior debt, mergers and acquisitions, lbo, development capital, discounted leveraged buyouts loans in mature companies and through co-investments in pre-ipo financing. within fund of fund investments, the firm invests in private equity funds and hedge funds. it seeks to invest in all sectors. it also prefers to invest in french and european smes/small cap and mid-cap companies. the firm primarily seeks to invest in france and european developed markets. the firm seeks to invest in €25 million ($26.81 million) and €60 million ($64.35 million) independently and up to €100+ million ($107.24 million) in co-investment. it generally makes an equity investment between €15 million ($16.28 million) and €150 million ($162.81 million). the firm prefers to invest between €15 million ($16.28 million) and €50 million ($54.27 million) in small and mid cap companies. it invests in companies with an enterprise value ranging between €10 million ($11.04 million) and €300 million ($331.34 million) with the capacity to exceed this limit on a case-by-case basis and invests between €5 million ($5.52 million) and €25 million ($27.14 million) per deal. it seeks to invest in funds with a fund size between $50 million and €300 million ($331.34 million). the amount it invest in each transactions ranges from €25 million ($27.14 million) and €50 million ($54.27 million) and upto €150 million ($162.81 million) in case of joint investments. the firm takes majority and minority stakes in companies with a focus on majority positions in small and medium-sized companies acquiring through leveraged buyouts. the firm mainly invests through its own capital in both direct and fund of funds investments. the firm prefers to invest from its balance sheet. idi was founded in 1970 and is based in paris, france with an additional office in paris, france.

earnings per share

as for profitability, idi has a trailing twelve months eps of €11.49.

pe ratio

idi has a trailing twelve months price to earnings ratio of 6.48. meaning, the purchaser of the share is investing €6.48 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.08%.

more news about idi.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic Enterprise Software Consolidates: Big Platforms Push Autonomy While Startups Get Absorbed
Enterprise software is shifting toward autonomous, AI-agent-driven products. SAP (Autonomous Enterprise, Joule), Meta (a new Enterprise Platform led by ex-MongoDB CEO Chirantan Desai) and UiPath (raised guidance) are pushing from the top. Meanwhile AI-security and governance startups are being acquired (Fortinet–Virtue AI, Harvey–Guardrails AI, Tiny–Oso Cloud) and seed-stage agent companies keep raising capital (Dextr, Latitude, Groq). Investors such as Norwest's Sean Jacobsohn see finance and ERP back-office software as the easier area to disrupt. Trust and enforced governance are treated as preconditions for regulated sectors like finance, and AI is judged unreliable for calculations.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,366 source documents archived
Query this data → isubstrate.com